10.11.2017
- Germany’s Boehringer Ingelheim is partnering US company Dicerna Pharmaceuticals to develop new RNAi therapeutics for liver diseases. The research collaboration and license...
15.05.2017
- Swiss pharma company Novartis has exercised an option that gives it global development and commercialization rights to a drug being developed by US biotech Conatus Pharmaceuticals...
08.05.2017
- Major drug makers Allergan and Novartis are collaborating to test a new combination therapy for non-alcoholic steatohepatitis (NASH), a progressive form of fatty liver disease said...
